DEVELOPMENT OF MODEL MOUSE FOR DIALYSIS-RELATED AMYLOIDOSIS AND ITS APPLICATION FOR THE ANALYSIS OF PATHOGENESIS.
DEVELOPMENT OF MODEL MOUSE FOR DIALYSIS-RELATED AMYLOIDOSIS AND ITS APPLICATION FOR THE ANALYSIS OF PATHOGENESIS.
批准号:
07671244
负责人:
GEJYO Fumitake
金额:
$0.19万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Long-term dialysis is very often complicated with amyloid deposits, predominantly in aricular synovial membranes. The amyloid deposition is a serious complication of dialysis as it excessively deteriorates the quality of life of long-term dialysis patients. A major component of amyloid deposits was identified as beta2-microglobulin (beta2-m) having a molecular weight of 11,800 daltons.The details of amyloidogenesis of this type of amyloid remain unknown. At present, a variety of the factors contributing to the pathogenesis have been proposed. They include calcium, amyloid P component, glycosaminoglycans, and collagens. Furthermore, macrophages, monokines, proteases, free radicals, and apolipoprotein E are also suggested to play roles in amyloid fibril formation. Although the mechanism is probably multifactorial, the retention of beta2-m, that is a precursor protein of this type of amyloid, is considered to be a principal requirement for the trigger of this processes.To analyze the mechanisms of amyloid deposition in dialysis-related amyloidosis, we have tried to develop a model mouse for the amyloidosis. Transgenic mice by microinjecting human beta2-m cDNA ligated with a MML virus DNA as a promoter were developed.Synovia and other organs were obtained from mice sacrificed at the age of between 3 months and 6 months, and examined histopathologically and immunohistochemically.There was no Congo red positive lesion in any organs and no significant staining with beta2-m antibody except liver.Studies are still in progress with long-term follow-up observation.
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Gejyo F., Suzuki S., Kimura H., et al.: "Increased risk of dialysis-related amyloidosis in the patients with apolipoprotein E4 allele." Amyloid : The International Journal of Experimental and Clinical Investigation.(in press).
Gejyo F.、Suzuki S.、Kimura H. 等人:“载脂蛋白 E4 等位基因患者患透析相关淀粉样变性的风险增加。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakazawa R., Azuma N., Suzuki M., Gejyou F., et al.: "Selective Extracorporeal Removal of β2-Microglobulin with Adsorbent Column in Dialysis-Related Amyloidosis." Japanese Journal of Apheresis.16. 126-127 (1997)
Nakazawa R.、Azuma N.、Suzuki M.、Gejyou F. 等人:“在透析相关淀粉样变性中使用吸附柱选择性体外去除 β2-微球蛋白。126-127(1997 年)” )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
下条文武: "透析アミロイドーシスの発症病理" 細胞. 29. 90-93 (1997)
Fumitake Shimojo:“透析淀粉样变性的病理学”细胞。29. 90-93 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Gejyo F.: Dialysis-related amyloidosis. (in Japanese). Nakayama-Shoten, 223-229 (1995)
Gejyo F.:透析相关淀粉样变性。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Gejyo F., et al.: Composition of beta2-microglobulin deposits. (Dialysis Amyloid). Oxford University Press., 159-172 (1996)
Gejyo F. 等人:β2-微球蛋白沉积物的成分。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 37 条
The study of the mechanisms of autoimmune systemic vasculitis.
-
批准号:12670420
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:GEJYO Fumitake
-
依托单位:
Studies on dialysis-related amyloid fibril formation by a in vitro kinetic model
-
批准号:10670992
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:1998
-
负责人:GEJYO Fumitake
-
依托单位:
海外基金